Trademark: 79327023
Status Date
Tuesday, September 27, 2022
Registration Number
6854772
Registration Date
Tuesday, September 27, 2022
Filing Date
Friday, September 24, 2021
Published for Opposition
Tuesday, July 12, 2022
5 Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases
Jan 23, 2023
Final Disposition Notice Sent To Ib
Jan 23, 2023
Final Disposition Processed
Dec 27, 2022
Final Disposition Notice Created, To Be Sent To Ib
Sep 27, 2022
Notice Of Registration Confirmation Emailed
Sep 27, 2022
Registered-Principal Register
Jul 19, 2022
Notification Processed By Ib
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2022
Published For Opposition
Jun 29, 2022
Notification Of Possible Opposition Sent To Ib
Jun 29, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
Jun 4, 2022
Approved For Pub - Principal Register
Jun 3, 2022
Teas/Email Correspondence Entered
Jun 3, 2022
Correspondence Received In Law Office
Jun 3, 2022
Teas Response To Office Action Received
Feb 20, 2022
Refusal Processed By Ib
Jan 28, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 28, 2022
Refusal Processed By Mpu
Jan 6, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 5, 2022
Non-Final Action Written
Jan 4, 2022
Assigned To Examiner
Dec 21, 2021
Application Filing Receipt Mailed
Dec 16, 2021
New Application Office Supplied Data Entered
Dec 15, 2021
Limitation From Original Application Entered
Dec 2, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
